Keryx Biopharmaceuticals (NASDAQ:KERX)
CAPS Rating:
A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.
RSS Headlines
Fool UK
Recs
biotech